Skip to content
Search

Latest Stories

Mumbai Saga: Emraan Hashmi looks damn good as a cop

Sanjay Gupta’s Mumbai Saga is one of the most awaited films of the year. The movie stars John Abraham and Emraan Hashmi in the lead roles. While John plays the role of a gangster, Emraan will be seen portraying the character of a cop in the movie.

A few days ago, the makers of the film had unveiled the first look of John Abraham, and now, they have released Emraan’s look as a cop. Director Sanjay Gupta took to Twitter to share the look of the actor. He tweeted, “Everyone on team MUMBAI SAGA was anxious about how @emraanhashmi would pull off the deadly cop’s look. Just look with what style he has pulled it off.”


In his second tweet, he wrote, “#MUMBAISAGA One of my favourite moments from the film. Grit and determination to get the bad guys at any cost writ large on his face.”

Well, we must say that Emraan is looking damn good in his cop avatar and we are quite impressed. While the actor has played the role of a gangster earlier, it will be interesting to see him playing a cop on the big screen.

Apart from John and Emraan, Mumbai Saga also stars Kajal Aggarwal, Jackie Shroff, Suniel Shetty, Prateik Babbar, Rohit Roy, Samir Soni, Amole Gupte, and Gulshan Grover. The movie is slated to hit the screens on 19th June 2020.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less